Braincool (BRAIN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
18 Feb, 2026Executive summary
Strong order intake at the start of 2026, with orders for base systems and consumables totaling at least SEK 48 million, indicating accelerated growth trajectory.
2025 results in line with expectations, reflecting increased but irregular distributor demand and a positive impact from cost optimization measures.
New CEO appointed in December 2025, with a focus on commercial growth and operational efficiency.
Financial highlights
Net sales for 2025 were SEK 36.2 million, down 9% year-over-year from SEK 40.0 million.
EBIT improved to -34.4 MSEK from -42.2 MSEK, an 18% year-over-year improvement.
Q4 2025 net sales were SEK 4.6 million, a 61% decrease compared to Q4 2024.
Cash position at year-end was SEK 39.6 million, up from SEK 31.4 million the previous year.
Earnings per share for 2025 were -0.15 SEK, compared to -0.20 SEK in 2024.
Outlook and guidance
Strong order backlog and distributor signals suggest further orders and continued high demand in 2026.
Focus on scaling production to meet longer-term delivery commitments and support sustainable, profitable growth.
Latest events from Braincool
- Record order backlog and robust US growth drive positive outlook despite ongoing losses.BRAIN
Q1 20266 May 2026 - Record sales and margin improvements mark a pivotal quarter amid global expansion.BRAIN
Q3 202524 Oct 2025 - Cost reductions and clinical advances offset lower Q2 sales, supporting long-term growth.BRAIN
Q2 202515 Aug 2025 - Q3 2024 net sales up 144% year-over-year, with margin gains and strong ZOLL®-driven growth.BRAIN
Q3 202413 Jun 2025 - Sales up 42% in Q2 2024, cash bolstered by rights issue, and ZOLL® partnership expanded.BRAIN
Q2 202413 Jun 2025 - Sales up 24% and gross margin improved as ZOLL® partnership and clinical trials advance.BRAIN
Q1 20256 Jun 2025 - Record sales and margin gains set the stage for further growth and profitability in 2025.BRAIN
Q4 20245 Jun 2025